Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- JACDS to Introduce Category Management
August 26, 2002
- HIL Amendment Opens Way to Major Reform of Health Insurance System: Korosho
August 26, 2002
- Korosho to Beef Up Control over Health Food
August 26, 2002
- JMA to Conclude Memo with LDP to Follow Up Law Amendment
August 26, 2002
- JPA Calls For Stricter Control over Health Food
August 26, 2002
- FY2003 Social Security-related Budget Request Up \691 Bil.
August 26, 2002
- OTC NEWS IN BRIEF
August 26, 2002
- MR-kun Used by 10 Companies: Mr Tanimura of So-net M3
August 26, 2002
- REGULATORY NEWS IN BRIEF
August 26, 2002
- DIAGNOSTIC NEWS IN BRIEF
August 26, 2002
- WORLD NEWS IN BRIEF
August 26, 2002
- BULLETIN -2-
August 26, 2002
- Korosho to Issue GLP for Medical Devices in September
August 26, 2002
- Taisho, Toyama Aiming at \300 Bil. Ethical Drug Sales in FY2015: Taisho President
August 26, 2002
- Kirin Develops Calves with Human Antibody Genes
August 26, 2002
- Guidant to Acquire Cook Group
August 26, 2002
- Teijin Aims at \200 Bil. Drug Sales via M&As, JV
August 26, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 26, 2002
- BULLETIN -3-
August 26, 2002
- Alliances Make Shionogi Accelerate Pharmacogenomic Research
August 26, 2002
ページ
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…